Modelling the cost-effectiveness of public awareness campaigns for the early detection of non-small-cell lung cancer.

作者: S Hinde , C McKenna , S Whyte , M D Peake , M E J Callister

DOI: 10.1038/BJC.2015.167

关键词:

摘要: Survival rates in lung cancer England are significantly lower than many similar countries. A range of Be Clear on Cancer (BCOC) campaigns have been conducted targeting and found to improve the proportion diagnoses at early stage disease. This paper considers cost-effectiveness such campaigns, evaluating effect both regional national BCOC distribution non-small-cell (NSCLC) diagnosis. natural history model NSCLC was developed using incidence data, data elicited from clinical experts calibration techniques. structure is used consider lifetime cost quality-adjusted survival implications awareness campaigns. Incremental ratios (ICERs) terms additional costs per life-years (QALYs) gained presented. Two scenario analyses were investigate role changes ‘worried-well’ population route diagnosis that might occur as a result The base-case theoretical be associated with QALY gains 289 178 QALYs ICERs £13 660 £18 173 gained, respectively. scenarios increases may impact conclusions. Subject available evidence, analysis suggests potential cost-effective. However, significant research required address limitations this study. In addition, estimated presents previously unavailable estimates prevalence rate disease progression undiagnosed population.

参考文章(19)
Karl Claxton, Steve Martin, Marta Soares, Nigel Rice, Eldon Spackman, Sebastian Hinde, Nancy Devlin, Peter C Smith, Mark Sculpher, Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold Health Technology Assessment. ,vol. 19, pp. 1- 504 ,(2015) , 10.3310/HTA19140
L Ironmonger, E Ohuma, N Ormiston-Smith, C Gildea, C S Thomson, M D Peake, An evaluation of the impact of large-scale interventions to raise public awareness of a lung cancer symptom British Journal of Cancer. ,vol. 112, pp. 207- 216 ,(2015) , 10.1038/BJC.2014.596
C Black, A Bagust, A Boland, S Walker, C McLeod, R De Verteuil, J Ayres, L Bain, S Thomas, D Godden, N Waugh, The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews. Health Technology Assessment. ,vol. 10, ,(2006) , 10.3310/HTA10030
Natasha K. Stout, Amy B. Knudsen, Chung Yin Kong, Pamela M. McMahon, G. Scott Gazelle, Calibration methods used in cancer simulation models and suggested reporting guidelines. PharmacoEconomics. ,vol. 27, pp. 533- 545 ,(2009) , 10.2165/11314830-000000000-00000
Ian Fleming, Pauline Monaghan, Anna Gavin, Ciaran O’Neill, Factors influencing hospital costs of lung cancer patients in Northern Ireland European Journal of Health Economics. ,vol. 9, pp. 79- 86 ,(2008) , 10.1007/S10198-007-0047-4
Milton C Weinstein, Recent developments in decision-analytic modelling for economic evaluation. PharmacoEconomics. ,vol. 24, pp. 1043- 1053 ,(2006) , 10.2165/00019053-200624110-00002
Julie Sturza, A review and meta-analysis of utility values for lung cancer. Medical Decision Making. ,vol. 30, pp. 685- 693 ,(2010) , 10.1177/0272989X10369004
DR Baldwin, SW Duffy, NJ Wald, R Page, DM Hansell, JK3063456 Field, None, UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer Thorax. ,vol. 66, pp. 308- 313 ,(2011) , 10.1136/THX.2010.152066